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BACKGROUND: The diagnosis of tuberculosis (TB) in children is challenging by the absence of a practical gold standard. Interferon (IFN)-g-
inducible protein 10 (IP-10) is a chemokine that may serve 
as the leading candidate marker in child TB diagnosis. The 
aim of this study is to assess the diagnostic value of IP-10 in 
the diagnosis of TB in children.
METHODS: We recruited eligible symptomatic and 
asymptomatic children aged <15 years actively by contact 
investigation and passively from inpatient and outpatient 
clinics in two hospitals, in Yogyakarta, Indonesia. We 
conducted clinical examination and chest X-ray in all 
eligible children. Sputum smear and the rapid molecular 
TB test were performed in children with TB symptoms. All 
participants underwent blood sampling for IFN-g Release 
Assay and IP-10 test.
RESULTS: A total of 79 children were recruited to this 
study. Twelve children were with TB disease, 16 with latent 
TB infection (LTBI), 40 were TB-exposed only and 11 were 
non-TB. Children with evidence of TB infection either with 
TB disease or LTBI had higher levels of antigen-stimulated 
IP-10 compared to non-infected children, both TB exposed 
only and non-TB (p=0.000). A cut-off 408.74 pg/mL for 
antigen-stimulated IP-10 showed high diagnostic accuracy 
for diagnosis of TB infection (AUC: 0.97, 95% CI: 0.92-
1.00, sensitivity: 92.3%, and specificity: 91.9%). However, 
the stimulated levels of IP-10 between children with TB 
disease and LTBI were not significantly different (p=0.268).
CONCLUSION: IP-10 performed well to diagnose 
TB infection in children. However, it cannot be used to 
differentiate TB infection from TB disease. 
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Abstract
Introduction
Tuberculosis (TB) contributes significantly to morbidity 
and mortality in children, especially in TB endemic settings.
(1) Globally, incidence of TB in children each year has 
reached nearly 1 million and children (0-14 years old) 
represent about 10-11% of all TB cases. The World Health 
Organization (WHO) estimated that 230,000 children died 
of TB in 2017, including 52,000 children with human 
immunodeficiency virus (HIV) associated TB.(2) However, 
the actual burden of TB in children is likely higher given the 
challenge in the diagnosis of TB in children. 
 TB diagnosis in children remains a significant 
challenge due to the lack of an established practical gold 
standard. Even with advanced molecular technologies, 
microbiological confirmation is often difficult because of the 
paucibacillary nature of the disease. Immunodiagnostic tests 
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may improve performance of diagnosis, but the current tests 
cannot discriminate infection from disease.(3) Accurate, 
timely, simple, and cheap diagnostic tools to distinguish 
patients with active disease from latent infection is an 
important priority for TB treatment in children. Adequate 
identification of active and latent TB cases is essential 
to direct effective treatment to cure and prevent relapse 
in patients with active disease or to provide appropriate 
preventive therapy.(4)
 Interferon (IFN)-g release assays (IGRA) are expected 
to improve the specificity of tuberculin skin testing (TST) 
for detection of latent TB infection. However, IGRA are 
costly and technically complex. The use of IGRA has not 
been recommended globally, limited by a countries’ income 
status since IGRA have suboptimal sensitivity when used in 
low and middle income countries, where the burden of TB 
is highest. Accuracy of IGRA is also compromised in the 
patients who are young and immunosuppressed.(5) 
 The IFN-g-inducible protein 10 (IP-10) is one of the 
promising candidate biomarkers which can improve the 
IGRA sensitivity and does not reduce specificity.(6) IP-10 
acts as downstream marker of IFN-γ, which is a commonly 
used marker for cell-mediated immunity. IP-10 promotes 
Th1 cells migration to infection sites by a process of 
binding with C-X-C motif chemokine receptor 3 (CXCR3) 
on T cells. Compared to IFN-γ, IP-10 is expressed in larger 
amounts while retaining the signal-to-noise ratio, and the 
protein’s stability in dried blood spots allows for innovation 
with simplified test platforms, especially lateral flow which 
implies a potential for a point of care diagnostic test.(7-9) 
Many clinical reports found that IP-10 release assays are 
comparable to IGRAs in terms of diagnostic accuracy.
(4,9-19) Presently, studies in children are limited and have 
inconsistent results. In view of these findings, this study 
aim to assess IP-10 as a novel TB diagnostic biomarker in 
children in endemic settings, specifically, for differentiating 
TB disease from TB infection.
Methods
Study Site and Population
An observational cross-sectional study was conducted in 
two hospitals in Yogyakarta, Indonesia from August 2017 
to April 2018. We recruited children aged <15 years in two 
approaches: a) passively, from symptomatic children who 
came to the study sites (inpatient and outpatient) during 
the study period; and b) actively by inviting children, both 
symptomatic and asymptomatic, who were in close contact 
with an adult TB case, who were treated in the study sites. 
Children who have been treated for TB were excluded. 
Informed consent was obtained from the parents or guardian 
before participation in the study. 
Symptom Screening and Investigations
All eligible children, irrespective of symptoms, underwent 
clinical evaluation including nutritional assessment, chest 
X-Ray (CXR), and blood sampling for quantiferon-TB gold 
in-tube (QFT-IT) assay and IP-10 test. Microbiological 
confirmation of sputum sample was performed in children 
with symptoms. A study doctor identified the symptom 
suggestive of TB (persistent cough >2 weeks, persistent 
fever >2 weeks, weight loss or failure to thrive recorded in 
last 3 months, and unexplained lethargy) as a “well-defined” 
symptom if meeting the criteria as previously described.(20)
The nutritional status was assessed based on weight for height 
(WFH) Z-scores (0-4 years) and percentage of expected 
WFH (≥5 years) from WHO criteria. WFH Z-scores >-2 or 
expected WFH >90% indicates well-nourished. Z-scores 
between -3 and -2 or expected WFH between 70-90% for 
moderate wasting and Z-scores <-3 or expected percentage 
WFH <70% for severe wasting.(21)
 The results of CXR in anteroposterior and lateral 
views were interpreted by an experienced radiologist and 
a pediatrician who were blinded to the clinical information. 
CXR was classified as “consistent with TB” if there was a 
concordant interpretation of any abnormality radiographic 
features of TB by reviewers. For microbiological 
confirmation, two separate induced sputum sample were 
collected from all symptomatic children. All sputum 
specimens were examined for acid-fast bacilli (AFB) and 
sputum pellets were analyzed for Xpert MTB/RIF assay 
(Cepheid, Sunnyvale, California). 
The QFT-IT Assay
The QFT-IT examination was done following standard 
protocol (Qiagen, Hilden, Germany), in which one mL 
of blood was drawn into each of three separate QFT-IT 
tubes: unstimulated tube (Nil), TB Antigen tube (Ag), 
and phytohemagglutinin tube as mitogen (Mit) and 
incubated at 37°C for 16 to 24 hours. After incubation, 
plasma supernatants were immediately collected by 
centrifugation and stored at –20°C until use.  IFN-γ  level 
was measured by QFT enzyme-linked immunosorbent 
assay (ELISA). QFT results were interpreted as positive, 
negative, or indeterminate according to the manufacturer’s 
recommendation. The antigen-dependent and mitogen-
stimulated IFN-γ levels were evaluated by subtracting the 
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level of IFN-γ in Nil vacutainer from the Ag vacutainer 
and Mit vacutainer, respectively. QFT results were defined 
by the antigen-dependent (Ag-Nil) IFN-γ value: positive 
result (≥0.35 IU/mL) and negative result (<0.35 IU/mL). 
The results were considered indeterminate if the mitogen-
stimulated (Mit-Nil) IFN-γ value ≤0.5 IU/mL and/or the 
value of the Nil IFN-γ ≥ 8.0 IU/mL. For comparison with 
IP-10 levels, the IFN-γ results were reported in pg/mL; 1 
IU/mL of IFN-γ equals to 50 pg/mL (NIBSC, Hertfordshire, 
UK). Aliquots of plasma from the QFT-IT tubes were stored 
at –80°C. 
IP-10 Assay
The IP-10 concentrations were measured from the same 
supernatants of QFT-IT using a Human IP-10 ELISA 
Construction Kit (RayBiotech, Georgia, USA) according 
to the manufacturer’s instructions. Samples were diluted 
1:2 and tested in duplicates. The results were expressed in 
pg/mL and classified as positive or negative according to 
a receiver operating curve (ROC). The test was considered 
indeterminate if the response of mitogen was less than 200 
pg/mL based on the earlier observation.(15)
Clinical Diagnoses
Based on the results of investigations, the children were 
diagnosed by a study doctor as: a) TB disease, either 
bacteriological confirmed or diagnosed clinically, if the 
child had positive result of sputum smear or Xpert MTB/
RIF or a child with well-defined symptoms of TB plus at 
least two of following three criteria: 1) positive IGRA result 
2) radiological findings consistent with TB, or 3) established 
history of close contact with a TB index case; b) latent TB 
infection (LTBI) if the child had a positive IGRA but did not 
meet the definition for TB disease; c) TB-exposed only if the 
child had a history of close contact with a TB index case, but 
did not meet the definitions for TB disease or LTBI; and d) 
non-TB if the child did not meet the criteria for TB disease, 
LTBI and TB-exposed only. 
 The study was approved by the Medical and Health 
Research Ethics Committee, Faculty of Medicine, Public 
Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 
Indonesia (No. KE/FK/0450/EC/2017).
Statistical Analysis
Subjects with indeterminate IGRA results were excluded 
from analysis. Since the IFN-γ and IP-10 values were not 
normally distributed, significant differences between the 
groups were determined using the nonparametric Kruskal-
Wallis test and the Mann-Whitney U-test for post-hoc 
analysis. The p-values were two-sided and considered 
significant if <0.05. Statistical analysis were performed 
using GraphPad Prism computer program (GraphPad 
Software Inc., San Diego, USA) and SPSS version 23.0 
(IBM Corporation, New York, USA). The diagnostic 
performances of IP-10 were evaluated with a ROC curve 
analysis to determine the area under the curve (AUC), 
their 95% confidence intervals (CI), and the optimal cutoff 
levels. Tests concordance was assessed by k-statistics 
and Spearman Rank Correlation was used to correlate 
continuous variables.
Results
A total of 79 children were included in the study. The 
demographic and clinical characteristics of the children 
are shown in Table 1. Twelve children had TB disease 
while 16 were with LTBI, 40 were TB-exposed only, and 
11 were non-TB. The median age of the children was 82 
months (interquartile range (IQR): 38-141), with 58% of 
the children aged more than 5 years. The majority of the 
children had close contact with a TB patient.
 The most common reported symptoms were cough 
(26.6%), failure to thrive or weight loss (22.8%), fever 
(13.9%), and lethargy (10.1%). Forty-three percent of 
children had abnormal CXR consistent with TB, with 
the commonest abnormality was hilar lymphadenopathy 


















Close contact to adult TB
Nutritional status
Table 1. Characteristics of the subjects.
TB: tuberculosis; BCG: bacille calmette guerin.
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symptomatic children and miliary pattern was in one 
symptomatic child. From 12 children with TB disease, three 
children were bacteriological confirmed, two of them had 
AFB sputum smear positive 1 and one of them had positive 
Xpert MTB/RIF.  Positive result of IGRA was documented 
in 26 (32.9%) children, negative result was in 44 (55.7%), 
and indeterminate was in 9 (11.4%).
Plasma Level of IP-10
Table 2 shows concentrations of IP-10 Nil, IP-10 Ag, IP-
10 Mit, IP-10 Ag-Nil, and IP-10 Mit-Nil in each group of 
children with TB disease, LTBI, TB-exposed only and non-
TB. Figure 1 shows that children with TB infection, either 
with TB disease or LTBI, had significantly higher levels 
of IP-10 Ag-Nil compared to non-infected TB children, 
both TB-exposed only and non-TB. The level of antigen-
stimulated IP-10 was increased in active TB and in latent 
TB, but there was no significant difference of stimulated 
levels of IP-10 between active TB and latent TB (p=0.268). 
There was also no significant difference of IP-10 levels in 
response to unstimulated and mitogen between the four 
groups (p>0.05 for all).
Performance of IP-10 for the Diagnosis TB Infection and 
TB Disease
The diagnostic value of IP-10 in identifying TB infection was 
evaluated by comparing the IP-10 levels between children 
with TB infection (either with TB disease or LTBI) and 
those who were TB-exposed only. The AUC of IP-10 Ag-
Nil in diagnosing TB infection was 0.970 (CI 95%: 0.921-
1.000, p=0.000). The cut-off IP-10 level to differentiate 
infected-TB child from healthy control was 408.74 pg/
mL (sensitivity: 92.3%, specificity: 91.9%). However, the 
diagnostic values of IP-10 in the unstimulated sample and 
in response to mitogen for diagnosis TB infection were poor 
(p>0.05). The AUC of IP-10 Nil, IP-10 Ag-Nil, and IP-10 
Mit-Nil for diagnosis of TB infection in children are shown 
in Figure 2.








IP-10 Nil 259.74 321.97 371.10 516.46 0.338
IP-10 Ag 438.92 3705.87 4815.78 576.38 ≤0.001
IP-10 Mit 1938.96 2571.65 2308.76 2858.08 0.784
IP-10 Ag-Nil 73.62 3304.30 4364.44 59.92 ≤0.001
IP-10 Mit-Nil 1554.06 2227.81 2048.05 2204.48 0.816
*tested with Kruskal-wallis. TB: tuberculosis; LTBI: latent TB infection; Nil: unstimulated; Ag: antigen; Mit: mitogen.
Table 2. The IP-10 levels (pg/mL) in response to unstimulated, TB antigens, or mitogen.
 To evaluate the diagnostic value of IP-10 in 
differentiating TB disease from TB infection, we compared 
the IP-10 levels of children with TB disease and those with 
LTBI. It was shown that it had poor diagnostic value with 
the AUC of IP-10 Nil was 0.528 (CI 95%: 0.281-0.775, 
p=0.813), the AUC of IP-10 Ag-Nil was 0.631 (CI 95%: 
0.378-0.885, p=0.268), and the AUC of IP-10 Mit-Nil was 
0.500 (CI 95%: 0.251-0.749, p=1.000). 
Comparison and Concordance between the IP-10 Assay 
and QFT-IT Test
We found that IP-10 was produced in higher level in plasma 
compared to IFN-γ after stimulation of M. tuberculosis 
specific antigen (Figure 3). The overall indeterminate rate 
of IP-10 was lower compared to QFT-IT (7.6% vs. 11.4%).
Moreover, we evaluated the correlation between the level 
of IP-10 and IFN-γ in response to antigen stimulation and 
the result showed a significant and high correlation between 
the two markers (rs=0.791, p=0.000). Based on the IP-10 
Ag-Nil cut-off previously identified for the diagnosis of 
TB infection, we scored the result positive and negative 
and evaluated the agreement between the IP-10 and QFT-
IT. Stratifying subjects according to their diagnosis, the 
concordance among all samples evaluated was optimal 
(k=0.837); in particular 24 patients scored positive in 
both assays, 34 patients scored negative, 3 patients scored 
positive in the IP-10 assay but negative in the QFT-IT test, 
and 2 patients scored negative in the IP-10 assay but positive 
in the QFT-IT test.
Our study found increased IP-10 expression in M. 
tuberculosis-infected individuals. This finding are similar 
with  other  reports  showing  elevated  IP-10  levels  not 
only in adults (4,10), but also in children (9,11-16), in 
households or in close contact with active TB patients 
Discussion
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Figure 1. The IP-10 levels levels among 
children with TB-exposed only, LTBI, TB 
disease, and non-TB. A: unstimulated  (Nil) 
IP-10 levels; B: antigen-stimulated (Ag-Nil) 
IP-10 levels; C: mitogen-stimulated (Mit-Nil) 
IP-10 levels. Horizontal lines indicate median 
values, *p<0.05. IP-10: IFN-g-nducible 
protein 10; TB: tuberculosis; LTBI: latent TB 
infection; ns: not significant.
(17,18), in individuals with immunocompromised 
conditions (19), and in animals.(22) These findings 
confirmed the role of chemokine IP-10 as a key regulator 
of immune cell recruitment, in particular Th1 cells, towards 
the site of infection or inflammation which is important in 
TB pathogenesis, especially in granuloma formation.(23)
 We also found that the diagnostic accuracy of IP-10 
in diagnosing TB infection was good at the cut-off point of 
408.74 pg/mL with sensitivity 92.3% and specificity 91.9%, 
which is comparable with QFT-IT. Several other studies 
found similar result, which were recently summarized in 
a review by another article.(24) Performance of IP-10 has 
been reported as comparable to that of IFN-γ, and was 
better in children and the immunocompromised patients.
(11,14,25,26) Two other systematic reviews also proposed 
IP-10 as a powerful reference marker in TB infection, with 
moderate accuracy (overall pooled sensitivity of 73% and 
specificity of 83%) for the detection of TB infection while 
performed alone. The diagnostic values were better when 
combined with other conventional tests such as TST or 
IGRA and clinical findings.(27,28)
 The use of IP-10 in distinguishing latent and active TB 
is  still  debatable.(29)  Although  we  found  that  stimulated 
IP-10 levels were higher in the active TB group compared 
to the latent TB group, this result was not statistically 
significant between the groups. Therefore, IP-10 could 
not be used to distinguish the two states of TB infection. 
Our findings support the previous studies demonstrating 
inability of IP-10 in identifying TB disease from latent 
TB infection.(4,26,30) Contrary to our study, there were 3 
studies in adults that showed the discriminative ability of 
IP-10 in diagnosing TB disease. One study indicated that 
IP-10, particularly in unstimulated plasma, serves as a 
potential biomarker to distinguish between active and latent 
TB with AUC of 0.86, sensitivity 80%, and specificity 80%.
(31) Another study also mentioned IP-10 Ag-Nil as a potent 
discriminative marker for active TB with AUC of 0.719, 
sensitivity 71.8%, and specificity 71.1%.(32) Discrimination 
between active and latent TB based on IP-10 assay was also 
reported by another research. They found IP-10 Ag-Nil with 
AUC of 0.8848, sensitivity 69.7%, and specificity100% 
could distinguish active and latent TB. They also revealed 
that ratio IP-10 Ag-Nil/ IP-10 Mit-Nil with AUC of 0.9242, 
sensitivity 93.94% and specificity 90% was the strongest 
promising indicator for active disease vs latent TB.(33)
 IP-10 plasma levels are often elevated during acute or 
chronic illness in inflammatory, infectious, and autoimmune 
diseases, as well as in several cancers.(34) Therefore, it is 
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     AUC IP-10 Nil  = 0.612 (CI 95% = 0.474-0.751, p=0.132)
     AUC IP-10 Ag-Nil = 0.970 (CI 95% = 0.921-1.000, p=0.000)
     AUC IP-10 Mit-Nil = 0.548 (CI 95% = 0.393-0.703, p=0.521)
Figure 2. Area under the curve of 
unstimulated (Nil) IP-10, antigen-stimulated 
(Ag-Nil) IP-10, and mitogen-stimulated (Mit-
Nil) IP-10 for diagnosis of TB infection in 
children. IP-10: IFN-g- inducible protein 10; 



















Figure 3. The comparison between median level of antigen-
stimulated  IP-10 and IFN-γ among children with TB-exposed 
only, LTBI, TB disease, and non-TB. IP-10: IFN-g-nducible 
protein 10; TB: tuberculosis; LTBI: latent TB infection.
not surprising that we found higher M. tuberculosis-antigen 
stimulated IP-10 responses in children with active TB than 
in the latent TB group or the TB exposed only as the high risk 
control group. Another possible reason for this finding could 
be that IP-10 secretion may be highest during primary M. 
tuberculosis infection, as it appears to play a central role in 
orchestrating the recruitment of Th1 cells during granuloma 
formation into the M. tuberculosis-infected lung, which 
contributes to M. tuberculosis containment.(14) Contrary 
with our results, previous studies found the background 
level of IP-10 was much higher in TB infection than TB 
disease, and they speculated that this could be because of a 
chronic state of inflammation due to the immune response 
in attempting to control the TB infection.(26) However, 
active TB has an immunosuppressive effect which changes 
cytokine responses providing an alternative explanation. A 
recent study raised a new topic on IP-10 antagonism that 
might be able to bridge the contrary findings. In addition to 
high levels of IP-10 in active TB patients, they also found 
high levels of IP-10 antagonism, which can inactivate IP-
10 then reducing its chemotactic functions in directing 
migration of Th1 cells to the site of infection.(35) How the 
chemokines, especially IP-10, drive the balance between 
protective and damaging inflammation, as well as the levels 
of inflammation required for M. tuberculosis containment 
remains a question that needs further investigation.
 Several studies that have been conducted in children 
have not shown good agreement on the diagnostic 
performance of IP-10 in M. tuberculosis infection with a wide 
range of sensitivity (63-95%) and specificity (53-100%). 
These results can be caused by different endemic level of TB 
and wide variation in the use of reference standards for the 
confirmation of cases, types of samples, dilution of samples, 
choice of M. tuberculosis antigen for stimulation, kits, test 
methods, and thresholds.(6,12,36-38) Modification of 
several components was suggested by another  publication 
in  an  effort  to  increase  IP-10 accuracy to distinguish 
active and latent conditions in TB. These include  using 
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M. tuberculosis  antigen  stimulant  specifically expressed 
under  replicative  or  dormant  conditions,  taking samples 
from  site  of  infection  or  using  combination of samples 
e.g., blood and urine, extending the duration of incubation, 
and combining IP-10 with other biomarkers.(39)
 The strength of this study is that we recruited 
symptomatic and asymptomatic children with active and 
passive approach of case finding, which allowed us to have 
wide spectrum of condition, from TB-exposed only, TB 
infection to TB disease. We also recruited children from 
both inpatient and outpatient clinics, therefore the spectrum 
of the disease was wide. Although IP-10 has not been able 
to replace the role of IFN-γ in detection of TB disease, 
IP-10 has technical advantages for the diagnosis of TB in 
children. This study and several previous studies found the 
rates of indeterminate results of IP-10 in children seemed to 
show a tendency towards fewer counts compared to IFN-γ.
(7) Expression of IP-10 is robust in infected TB children 
and quantitatively higher > 100x than IFN-γ.(22) It can 
be caused of IP-10 is a downstream marker compared to 
IFN-γ and other classical T cell cytokines in cell mediated 
immune respon assays.(24) High concentrations of IP-
10 allow detection of small specimens such as taking 
from blood capillary from the fingertips so that it is more 
feasible conducted in children.(7) The stable nature of IP-
10 in the dried plasma spots in the filter paper at ambient 
temperature ease in transportation while also allowing for 
the development of rapid tests in the form of a lateral flow 
test such as HIV testing and pregnancy test.(40)
 However, several limitations should be considered. 
First, the lack of a gold standard to diagnose TB in child 
may cause a source population bias. We classified patients 
based on combination of clinical features, microbiology 
confirmation, evidence of infection include immunological 
evidence and contact history, and CXR finding. Following 
up children to evaluate the response to TB treatment 
might increase the accuracy of TB disease. Second, the 
small sample population could produce type II error in the 
statistical analysis.
Conclusion
IP-10 provides a new specific biomarker for TB infection, 
but IP-10 does not appear to be superior than IFNγ in 
distinguishing active TB disease from latent TB infection. 
These findings contribute to our understanding of IP-10 
as a potential inflammatory marker in the blood. Studies 
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